These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 2611486)

  • 21. Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease.
    Drukarch B; Leysen JE; Stoof JC
    Life Sci; 1988; 42(9):1011-7. PubMed ID: 2893967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors?
    Nilsson L; Adem A; Hardy J; Winblad B; Nordberg A
    J Neural Transm; 1987; 70(3-4):357-68. PubMed ID: 3681290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase.
    Adem A; Jossan SS; Oreland L
    Neurosci Lett; 1989 Dec; 107(1-3):313-7. PubMed ID: 2616041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fluoxetine on basal and K(+)-induced tritium release from synaptosomes preloaded with [3H]serotonin.
    Gobbi M; Crespi D; Mennini T
    Life Sci; 1995; 56(10):785-91. PubMed ID: 7533873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
    Marquis JK
    Biochem Pharmacol; 1990 Sep; 40(5):1071-6. PubMed ID: 2390104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of verapamil on the release of different neurotransmitters.
    Sitges M; Reyes A
    J Neurosci Res; 1995 Apr; 40(5):613-21. PubMed ID: 7602614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
    Nielsen JA; Mena EE; Williams IH; Nocerini MR; Liston D
    Eur J Pharmacol; 1989 Nov; 173(1):53-64. PubMed ID: 2606156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser.
    Gobbi M; Mennini T
    Eur J Pharmacol; 1999 Apr; 370(1):23-6. PubMed ID: 10323276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of subchronic pretreatment with D-fenfluramine or p-chloroamphetamine on [3H]inositolmonophosphate accumulation in rat cortical miniprisms.
    Erfurth A; Gardier AM; Ribeiro E; Wurtman RJ
    Brain Res; 1994 Nov; 665(1):107-14. PubMed ID: 7882002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.
    Wells GB; Lopez MC; Tanaka JC
    Brain Res Bull; 1999 Apr; 48(6):641-7. PubMed ID: 10386845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.
    Niddam R; Arbilla S; Scatton B; Dennis T; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):123-7. PubMed ID: 4010791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efflux of 5-hydroxytryptamine from synaptosomes of rat cerebral cortex.
    Ross SB; Kelder D
    Acta Physiol Scand; 1977 Jan; 99(1):27-36. PubMed ID: 842362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic action in the nucleus accumbens: modulation of dopamine and acetylcholine release.
    de Belleroche JS; Gardiner IM
    Br J Pharmacol; 1982 Feb; 75(2):359-65. PubMed ID: 7186823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice.
    Tani Y; Saito K; Tsuneyoshi A; Imoto M; Ohno T
    Psychopharmacology (Berl); 1997 Feb; 129(3):225-32. PubMed ID: 9084060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes.
    Giambalvo CT; Price LH
    Synapse; 2003 Dec; 50(3):212-22. PubMed ID: 14515339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of endogenous catecholamines from isolated rat brain tissue by fenfluramine and N-ethylamphetamine--effects of pargyline.
    Tessel RE; Burgess SK; Rutledge CO
    Biochem Pharmacol; 1978; 27(12):1631-6. PubMed ID: 697904
    [No Abstract]   [Full Text] [Related]  

  • 40. Interaction of 9-amino-1,2,3,4-tetrahydroaminoacridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro.
    Perry EK; Smith CJ; Court JA; Bonham JR; Rodway M; Atack JR
    Neurosci Lett; 1988 Aug; 91(2):211-6. PubMed ID: 3185960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.